Literature DB >> 15927651

Current staging of esophageal carcinoma.

Amit N Patel1, Percival O Buenaventura.   

Abstract

The rational treatment of esophageal cancer requires the complete evaluation and preoperative staging of this disease. As the incidence of esophageal cancer increases, more clinicians will face the difficult task of allocating the appropriate treatment course for these patients. Accurate esophageal cancer staging is critical if stage-dependent algorithms are used to direct appropriate therapies. Although all of the staging techniques discussed may potentially provide useful information, it is not possible to use all techniques in all patients, especially given the limited availability of resources. The optimal staging strategy has not yet been determined; the authors provide the general algorithm used in our institution. Ultimately,minimally invasive surgical approaches will allow surgeons to evaluate locoregional disease with little or no procedure-associated morbidity, much as mediastinoscopy is used in lung cancer staging. Although currently the use of molecular biologic techniques may only be investigational, it holds great promise in the future.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15927651     DOI: 10.1016/j.suc.2005.01.012

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN: 0039-6109            Impact factor:   2.741


  5 in total

1.  Laparoscopic-assisted esophagectomy for adenocarcinoma of the esophagus.

Authors:  Martin I Montenovo
Journal:  Medscape J Med       Date:  2008-12-10

Review 2.  [Oesophageal tumours--what does the surgeon need from the radiologist?].

Authors:  H Feussner; M Feith
Journal:  Radiologe       Date:  2007-02       Impact factor: 0.635

Review 3.  The role of FDG-PET and staging laparoscopy in the management of patients with cancer of the esophagus or gastroesophageal junction.

Authors:  Harry H Yoon; Val J Lowe; Stephen D Cassivi; Yvonne Romero
Journal:  Gastroenterol Clin North Am       Date:  2009-03       Impact factor: 3.806

4.  Survival based radiographic-grouping for esophageal squamous cell carcinoma may impact clinical T stage.

Authors:  Wenjie Cai; Jiade J Lu; Rongyu Xu; Peiling Xin; Jun Xin; Yayun Chen; Bingzhong Gao; Jieyun Chen; Xiyang Yang
Journal:  Oncotarget       Date:  2018-01-09

Review 5.  Minimally invasive surgery and cancer: controversies part 1.

Authors:  Melanie Goldfarb; Steven Brower; S D Schwaitzberg
Journal:  Surg Endosc       Date:  2009-07-02       Impact factor: 4.584

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.